NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
NHS England
Published on NHS Health Family Atamis procurement portal
This tender has closed
The submission deadline for this contract has passed. There may be more active goods tenders from NHS England, and hundreds more across the UK public sector.
Key details
Procurement
- 33651520 Immunoglobulins
What happened
NHS England awarded this contract to CSL Behring UK Ltd | Bio Products Laboratory Ltd | Takeda UK Ltd | Grifols UK Ltd. | Octapharma Limited | LFB worth £905,187,090 on 19 Dec 2024. The contract runs until 31 Dec 2027.
Description
NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
Offer reference number: CM/PHS/23/5703
The period of the framework is 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months.
Awarded suppliers (6)
- CSL Behring UK Ltd
- Bio Products Laboratory Ltd
- Takeda UK Ltd
- Grifols UK Ltd.
- Octapharma Limited
- LFB
Contact
Identifiers
Explore related tenders
Other tenders from NHS England
View all →External ID: cf-ocds-b5fd17-63eefe2c-af75-4320-8392-e35c49eff8b9 • Added 3 October 2026